These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation. Grabbe S; Bruvers S; Lindgren AM; Hosoi J; Tan KC; Granstein RD J Leukoc Biol; 1992 Aug; 52(2):209-17. PubMed ID: 1506778 [TBL] [Abstract][Full Text] [Related]
4. Modulation of antigen-presenting cell function as a potential regulatory mechanism in tumor-host immune reactions. Grabbe S; Granstein RD In Vivo; 1993; 7(3):265-9. PubMed ID: 8357968 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. Torii H; Hosoi J; Beissert S; Xu S; Fox FE; Asahina A; Takashima A; Rook AH; Granstein RD J Leukoc Biol; 1997 Feb; 61(2):216-23. PubMed ID: 9021928 [TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity. Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743 [TBL] [Abstract][Full Text] [Related]
11. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Chang CH; Furue M; Tamaki K Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579 [TBL] [Abstract][Full Text] [Related]
15. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Chang CH; Furue M; Tamaki K Eur J Immunol; 1995 Feb; 25(2):394-8. PubMed ID: 7533084 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Ozawa H; Aiba S; Nakagawa ; Tagami H Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933 [TBL] [Abstract][Full Text] [Related]
18. IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression. Takayama K; Yokozeki H; Ghoreishi M; Satoh T; Katayama I; Umeda T; Nishioka K J Invest Dermatol; 1999 Oct; 113(4):541-6. PubMed ID: 10504438 [TBL] [Abstract][Full Text] [Related]
19. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Aiba S; Manome H; Yoshino Y; Tagami H Immunology; 2000 Sep; 101(1):68-75. PubMed ID: 11012755 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response. Epstein SP; Baer RL; Thorbecke GJ; Belsito DV J Invest Dermatol; 1991 Jun; 96(6):832-7. PubMed ID: 2045671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]